ATE451096T1 - Peptidderivate oder deren pharmazeutisch annehmbare salze, verfahren zu deren herstellung, verwendung dieser derivate und arzneimittel - Google Patents
Peptidderivate oder deren pharmazeutisch annehmbare salze, verfahren zu deren herstellung, verwendung dieser derivate und arzneimittelInfo
- Publication number
- ATE451096T1 ATE451096T1 AT98935447T AT98935447T ATE451096T1 AT E451096 T1 ATE451096 T1 AT E451096T1 AT 98935447 T AT98935447 T AT 98935447T AT 98935447 T AT98935447 T AT 98935447T AT E451096 T1 ATE451096 T1 AT E451096T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- acceptable salts
- pharmaceutically acceptable
- production
- medicinal products
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 3
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000001088 anti-asthma Effects 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000000141 anti-hypoxic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000002001 anti-metastasis Effects 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 230000010030 glucose lowering effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU97111091/04A RU2141483C1 (ru) | 1997-07-04 | 1997-07-04 | Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция |
| PCT/RU1998/000215 WO1999001103A2 (en) | 1997-07-04 | 1998-07-03 | Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE451096T1 true ATE451096T1 (de) | 2009-12-15 |
Family
ID=20194786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98935447T ATE451096T1 (de) | 1997-07-04 | 1998-07-03 | Peptidderivate oder deren pharmazeutisch annehmbare salze, verfahren zu deren herstellung, verwendung dieser derivate und arzneimittel |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP2229935A1 (de) |
| AT (1) | ATE451096T1 (de) |
| AU (1) | AU8469498A (de) |
| CY (1) | CY1109869T1 (de) |
| DE (1) | DE69841367D1 (de) |
| DK (1) | DK1020179T3 (de) |
| ES (1) | ES2337964T3 (de) |
| PT (1) | PT1020179E (de) |
| RU (1) | RU2141483C1 (de) |
| UA (1) | UA70301C2 (de) |
| WO (1) | WO1999001103A2 (de) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1581400A (en) * | 1999-12-22 | 2001-07-03 | Om Pharma | Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| HUP0303085A2 (hu) * | 2000-09-27 | 2003-12-29 | The Procter & Gamble Co. | Melanokortin receptor ligandumok és ezeket tartalmazó gyógyszerkészítmények |
| RU2178710C1 (ru) * | 2001-02-08 | 2002-01-27 | Кожемякин Леонид Андреевич | Индивидуальные вещества, полученные на основе химического взаимодействия дисульфидсодержащих пептидов с производными пуриновых или пиримидиновых оснований, фармацевтические композиции и препараты на их основе, способы их применения для лечения инфекционных заболеваний и профилактики осложнений |
| JP4156825B2 (ja) * | 2001-11-01 | 2008-09-24 | 株式会社ロッテ | 抗鬱・抗ストレス剤及びそれを含有する組成物 |
| RU2217196C2 (ru) * | 2002-02-28 | 2003-11-27 | Небольсин Владимир Евгеньевич | Способ индукции дифференцировки клеток |
| MC200060A1 (fr) | 2002-10-04 | 2003-05-28 | M Exsymol Sa | Produit de couplage entre la tryptamine et un alpha-aminoacide son procédé de préparation et son application dans le domaine de la neuro-cosmétique |
| JP2006143667A (ja) * | 2004-11-22 | 2006-06-08 | Ube Ind Ltd | ピペコリン酸アミド誘導体及び抗菌剤 |
| RU2335495C2 (ru) * | 2005-06-15 | 2008-10-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | N-ацильные производные аминокислот, их фармацевтически приемлевые соли, фармацевтическая композиция и применение в качестве гиполипидемических средств |
| RU2330680C2 (ru) * | 2005-12-09 | 2008-08-10 | Государственное учреждение Научно-исследовательский институт фармакологии имени В.В. Закусова Российской академии медицинских наук | Инъекционная лекарственная форма для лечения острого инсульта, способ ее изготовления и применение |
| RU2308966C1 (ru) * | 2006-05-18 | 2007-10-27 | Институт физиологически активных веществ Российской Академии Наук (ИФАВ РАН) | Антиметастатическая композиция |
| MX2009008641A (es) | 2007-02-13 | 2009-09-14 | Sciclone Pharmaceuticals Inc | Composiciones para el tratamiento o prevencion del deterioro, lesion o daño a tejido debido a enfermedad de las mucosas. |
| GB2437429A (en) * | 2007-06-11 | 2007-10-24 | Valletta Health Bv | Urocanic acid derivatives |
| RU2327486C1 (ru) * | 2007-07-04 | 2008-06-27 | Валентина Васильевна Малиновская | Лекарственное средство для лечения инфекционно-воспалительных заболеваний, обладающее иммуномодулирующим, антивирусным, антибактериальным, антиоксидантным, мембраностабилизирующим, противовоспалительным, антитоксическим свойствами |
| RU2326688C1 (ru) * | 2007-08-13 | 2008-06-20 | Валентина Васильевна Малиновская | Гипоаллергенное лекарственное средство для лечения инфекционно-воспалительных заболеваний различной этиологии |
| UA98508C2 (ru) * | 2007-08-23 | 2012-05-25 | Сайклон Фармасьютикалз, Инк. | Иммуномодуляторное производное дипептида для лечения рака легких |
| RU2378284C2 (ru) * | 2008-02-13 | 2010-01-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Способы получения n-ацильных производных аминокислот (варианты) |
| RU2406727C2 (ru) * | 2008-02-13 | 2010-12-20 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Фармацевтическая композиция, содержащая n-ацильные производные аминокислот, и их применение в качестве противоаллергических, антианафилактических и противовоспалительных средств |
| RU2373934C1 (ru) * | 2008-03-19 | 2009-11-27 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств |
| CN102014897B (zh) | 2008-04-21 | 2015-08-05 | 西格纳姆生物科学公司 | 化合物、组合物和其制备方法 |
| FR2942625B1 (fr) * | 2009-03-02 | 2013-11-22 | Centre Nat Rech Scient | Derives indoliques pour le traitement de maladies neurodegeneratives |
| US9504673B2 (en) | 2009-05-21 | 2016-11-29 | LTD “Valenta-Intellekt” | Agent for the prophylaxis and treatment of highly pathogenic infectious diseases |
| AU2010306750B2 (en) * | 2009-10-15 | 2014-11-13 | Children's Medical Center Corporation | Sepiapterin reductase inhibitors for the treatment of pain |
| JP2012097068A (ja) * | 2010-10-04 | 2012-05-24 | Sumitomo Chemical Co Ltd | 植物の水分ストレスによる影響を軽減する方法 |
| EA201391419A1 (ru) * | 2011-03-31 | 2014-02-28 | Апотекс Текнолоджиз Инк. | Пролекарства d-изоглутамил-[d/l]-триптофана |
| UA115431C2 (uk) | 2011-10-11 | 2017-11-10 | Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" | Застосування глутарилгістаміну для лікування захворювань дихальних шляхів |
| RU2484844C1 (ru) * | 2012-03-01 | 2013-06-20 | Закрытое акционерное общество "Инновационный научно-производственный центр "Пептоген" | Способ профилактики и лечения осложнений сахарного диабета, связанных с развитием дегенеративных процессов в нервной ткани, фармацевтическая композиция для нейропротективной терапии таких осложнений и способ ее получения |
| RU2496512C1 (ru) * | 2012-03-14 | 2013-10-27 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Способ лечения вирусного гепатита с |
| RU2503459C2 (ru) * | 2012-03-22 | 2014-01-10 | Николай Николаевич Каркищенко | Средство для стимуляции работы в экстремальных условиях, способ его получения и его применения |
| CN102757387B (zh) * | 2012-07-04 | 2015-10-28 | 四川百利药业有限责任公司 | 一种英加韦林的合成方法 |
| CN102757388B (zh) * | 2012-07-04 | 2015-05-20 | 四川百利药业有限责任公司 | 一种高纯度英加韦林的制备方法 |
| RU2518314C2 (ru) * | 2012-08-30 | 2014-06-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Способ и средство активации irf-3 для лечения и профилактики заболеваний, вызываемых (+) phk-содержащими вирусами |
| EA201591465A1 (ru) | 2013-02-08 | 2015-12-30 | АйАрЭм ЭлЭлСи | Специфичные участки для модификации антител для получения иммуноконъюгатов |
| EP3722290B1 (de) | 2013-04-12 | 2023-06-21 | VALENTA-INTELLEKT Limited | Glutarimidderivat, verwendung davon, darauf basierende pharmazeutische zusammensetzung und verfahren zur herstellung vom glutarimidderivat |
| CN103382179A (zh) * | 2013-06-05 | 2013-11-06 | 四川百利药业有限责任公司 | 英加韦林的多晶型物及其制备方法 |
| RU2613314C2 (ru) * | 2013-06-28 | 2017-03-15 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" | Малые молекулы с NGF-подобной активностью, обладающие антидиабетическими свойствами |
| RU2595862C2 (ru) | 2013-09-03 | 2016-08-27 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Способ профилактики или лечения заболеваний, связанных с пониженной плотностью интерфероновых рецепторов |
| RU2552929C1 (ru) | 2013-11-14 | 2015-06-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний |
| RU2546002C1 (ru) * | 2014-01-20 | 2015-04-10 | Общество с ограниченной ответственностью ООО "ВАЛЕНТА-ИНТЕЛЛЕКТ" | Фармацевтическая композиция в форме таблетки и способ ее получения |
| RU2628800C2 (ru) * | 2014-03-12 | 2017-08-22 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами |
| CN105418512B (zh) * | 2014-09-19 | 2018-05-01 | 江苏正大丰海制药有限公司 | 英加韦林的单晶、制备方法及其药物组合物 |
| KR101861081B1 (ko) * | 2015-08-05 | 2018-05-28 | 인제대학교 산학협력단 | 멜라토닌 유도체를 포함하는 염증성 질환, 알러지 질환 또는 암 질환 예방 또는 치료용 조성물 |
| CN109153644B (zh) | 2016-03-16 | 2022-10-21 | H·李·莫菲特癌症中心研究有限公司 | 用以增强效应t细胞功能的针对cereblon的小分子 |
| RU2668538C1 (ru) * | 2016-07-18 | 2018-10-01 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Способ восстановления плотности интерфероновых рецепторов для профилактики или лечения заболеваний, связанных с пониженной плотностью интерфероновых рецепторов |
| RU2665638C1 (ru) * | 2017-05-24 | 2018-09-03 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Амидное соединение и его применение в качестве средства для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами |
| AU2018354090B2 (en) | 2017-10-23 | 2024-10-24 | Epitracker, Inc. | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome |
| EP3796976A4 (de) | 2018-05-23 | 2022-03-30 | Epitracker, Inc. | Zusammensetzungen und verfahren zur diagnose und behandlung von alterungs- und langlebigen bedingungen |
| EP3820532A4 (de) | 2018-07-11 | 2022-04-06 | H. Lee Moffitt Cancer Center & Research Institute, Inc. | Dimere immunmodulatorische verbindungen gegen cereblonbasierte mechanismen |
| KR102100843B1 (ko) * | 2018-08-08 | 2020-04-14 | 샘표식품 주식회사 | 항산화 활성을 갖는 펩타이드 및 이를 포함하는 조성물 |
| EP3908374A4 (de) * | 2019-01-09 | 2022-12-28 | Epitracker, Inc. | Zusammensetzungen und verfahren zur diagnose und behandlung von neurodegenerativen erkrankungen |
| JP7404382B2 (ja) | 2019-03-04 | 2023-12-25 | エピトラッカー インコーポレイテッド | 脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用 |
| RU2745265C2 (ru) * | 2019-09-12 | 2021-03-22 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Новые составы 2-(имидазол-4-ил)-этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний |
| RU2746692C1 (ru) * | 2020-04-14 | 2021-04-19 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Новые составы 2-(имидазол-4-ил)-этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний |
| WO2021049980A1 (ru) * | 2019-09-12 | 2021-03-18 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Новые составы для лечения и профилактики вирусных заболеваний |
| RU2744854C1 (ru) * | 2020-02-11 | 2021-03-16 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Жидкая лекарственная форма для лечения и профилактики гриппа и орви |
| RU2767030C1 (ru) * | 2021-05-20 | 2022-03-16 | Акционерное общество "Опытно-Экспериментальный завод "ВладМиВа" | Способ получения пептида Ac-His-Ala-Glu-Glu-NH2 |
| JP2024539823A (ja) | 2021-11-03 | 2024-10-31 | エピトラッカー インコーポレイテッド | 老化の質および寿命に関係する状態の治療のためのペンタデカノイルカルニチン |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2238545A1 (de) * | 1972-08-04 | 1974-02-14 | Shionogi & Co | Corticotropin-peptide enthaltende arzneimittel und verfahren zu ihrer herstellung |
| JPS52111572A (en) * | 1976-03-16 | 1977-09-19 | Santen Pharmaceutical Co Ltd | Nn*mercapto substituted acyl**hystidine |
| GB1592552A (en) * | 1976-12-10 | 1981-07-08 | Inst Nat Sante Rech Med | Pseudopeptides used as medicaments |
| IL58849A (en) * | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
| JPS57108072A (en) * | 1980-12-18 | 1982-07-05 | Ajinomoto Co Inc | Preparation of n-acylcarnosine |
| US5110799A (en) * | 1989-07-28 | 1992-05-05 | Merck & Co., Inc. | Antiherpetic agents |
| FR2652004B1 (fr) * | 1989-09-21 | 1994-10-28 | Immunotech Partners | Nouveaux derives hydrophiles, application au diagnostic et a la therapeutique, kits diagnostiques ou therapeutiques et reactifs immunologiques. |
| RU2030422C1 (ru) * | 1990-04-27 | 1995-03-10 | Фармацевтическое акционерное общество "Феррейн" | Способ получения карнозина |
| DE4228717A1 (de) * | 1992-08-28 | 1994-03-03 | Cassella Ag | Imidazolidin-Derivate |
| FR2701948B1 (fr) * | 1993-02-22 | 1996-07-26 | Exsymol Sa | Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires. |
| GB9308695D0 (en) * | 1993-04-27 | 1993-06-09 | Celltech Ltd | Peptidyl derivatives |
| IT1270905B (it) * | 1993-10-15 | 1997-05-13 | Bruschettini Srl | Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta |
| FR2711990B1 (fr) * | 1993-11-05 | 1995-12-08 | Exsymol Sa | Produit pseudodipeptide possédant un groupement imidazole, et applications thérapeutiques, cosmétologiques et agroalimentaires. |
| RU2080120C1 (ru) * | 1994-07-19 | 1997-05-27 | Совместное русско-американское акционерное общество закрытого типа "Неофарм" | Средство, обладающее иммуномодулирующей активностью |
| IT1275434B (it) * | 1995-05-19 | 1997-08-07 | Farmila Farma Milano | Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante |
| RU2091389C1 (ru) * | 1995-11-28 | 1997-09-27 | Товарищество с ограниченной ответственностью "Верта" | Пептид, обладающий иммуномодулирующей активностью |
-
1997
- 1997-07-04 RU RU97111091/04A patent/RU2141483C1/ru active Protection Beyond IP Right Term
-
1998
- 1998-03-07 UA UA2000010044A patent/UA70301C2/uk unknown
- 1998-07-03 AT AT98935447T patent/ATE451096T1/de active
- 1998-07-03 EP EP08006502A patent/EP2229935A1/de not_active Withdrawn
- 1998-07-03 WO PCT/RU1998/000215 patent/WO1999001103A2/ru not_active Ceased
- 1998-07-03 ES ES98935447T patent/ES2337964T3/es not_active Expired - Lifetime
- 1998-07-03 DK DK98935447.7T patent/DK1020179T3/da active
- 1998-07-03 AU AU84694/98A patent/AU8469498A/en not_active Abandoned
- 1998-07-03 EP EP98935447A patent/EP1020179B9/de not_active Expired - Lifetime
- 1998-07-03 PT PT98935447T patent/PT1020179E/pt unknown
- 1998-07-03 DE DE69841367T patent/DE69841367D1/de not_active Expired - Lifetime
-
2010
- 2010-03-04 CY CY20101100206T patent/CY1109869T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999001103A2 (en) | 1999-01-14 |
| WO1999001103A3 (en) | 1999-03-25 |
| EP1020179A4 (de) | 2003-02-19 |
| EP2229935A1 (de) | 2010-09-22 |
| AU8469498A (en) | 1999-01-25 |
| CY1109869T1 (el) | 2014-09-10 |
| EP1020179B1 (de) | 2009-12-09 |
| EP1020179B9 (de) | 2011-02-02 |
| UA70301C2 (uk) | 2004-10-15 |
| DE69841367D1 (de) | 2010-01-21 |
| EP1020179A2 (de) | 2000-07-19 |
| PT1020179E (pt) | 2010-03-15 |
| RU2141483C1 (ru) | 1999-11-20 |
| DK1020179T3 (da) | 2010-04-19 |
| ES2337964T3 (es) | 2010-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69841367D1 (de) | Peptidderivate oder deren pharmazeutisch annehmbare salze, verfahren zu deren herstellung, verwendung dieser derivate und arzneimittel | |
| GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
| BR9306841A (pt) | Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico | |
| CA2093806A1 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
| GEP20043324B (en) | Purine Derivatives | |
| NO166448C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner. | |
| BG103430A (en) | FACTOR Xa INHIBITING HETEROCYCLIC DERIVATIVES | |
| PT87542A (pt) | Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease | |
| CA2143610A1 (en) | Use of norastemizole for the treatment of allergic disorders | |
| AU1277792A (en) | Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts | |
| ES2147788T3 (es) | 3,4-diarilcromanos para el tratamiento de la dermatitis. | |
| ATE268174T1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
| ATE161531T1 (de) | Acridine-1,8-dionderivate als therapeutisches mittel | |
| NO172043C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater | |
| ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
| IL148739A0 (en) | 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use | |
| ATE183088T1 (de) | Arzneimittel zur behandlung von hauterkrankungen | |
| CY1106819T1 (el) | Φαρμακα για το ξηρο δερμα | |
| DE3688787D1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
| AU7076494A (en) | Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease | |
| CY1106168T1 (el) | Συνθεση για την προληψη και/ή θepαπεια αγγειακων ασθενειων που συνισταται απο προπιονυλ l-καρνιτινη και συνενζυμο q10 | |
| DE69429447D1 (de) | Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen | |
| HUT56716A (en) | Process for producing pharmaceutical compositions suitable for preventing and treating autoimmune illnesses and skin diseases caused by heat and light radiation | |
| HUP9901348A2 (hu) | Tumor elleni hatású 2-[2-[(2-hidroxi-etil)-amino]-etil]-5-[[2-(metil-amino)-etil]-amino]-indazolo[4,3-gh]izokinolin-6(2H)-on-származékok, előállításuk, intermedierek és e vegyületeket tartalmazó gyógyszerkészítmények | |
| ITMI910133A1 (it) | Derivati salini del gliceril fosforil mioinositolo ad attivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1020179 Country of ref document: EP |